WEBINAR
Driving Quality and Growth with The CardioCare® Platform
During this 45-minute session, we cover how CardioCare can:
- Support health systems in delivering on quality and financial goals
- Identify treatment-eligible patients earlier to drive better outcomes
- Use actionable population health analytics to move from insight to action
Dr. Daniel Logsdon Cardiothoracic Surgeon Eisenhower Health
Key Insights from Dr. Daniel Logsdon
The Cost of Late Diagnosis
Patients with critical aortic stenosis are often identified only after an emergency event, leading to emergent TAVR procedures, poorer outcomes, financial strain, and operational disruption. Earlier visibility can help prevent avoidable emergencies and reduce stress on care teams.
Why Earlier Patient Identification Matters
Earlier identification is critical to the future of cardiovascular care. Better visibility into patient populations can support earlier intervention, program growth, and greater efficiency from diagnosis to treatment. Data also shows that earlier treatment of aortic stenosis can improve survival and long-term heart function.
When Manual Processes Reach Their Limit
Many cardiovascular programs rely on spreadsheets, chart reviews, and manual outreach to identify and manage aortic stenosis patients. While effective at first, these processes can become difficult to scale as patient volumes grow, creating challenges in patient stratification, follow-up, and care coordination.
Finding Patients Falling Through the Cracks
Even when effective treatments are available, some severe aortic stenosis patients may face delays in care. By identifying where patients stall in the treatment pathway, cardiovascular teams can focus on removing barriers and accelerating access to intervention.
CARDIOCARE RESOURCES
See What Leading Cardiovascular Programs Are Doing
Built as an end-to-end solution, the CardioCare Platform supports cardiovascular teams by automatically identifying eligible patients and managing them from diagnosis through treatment—reducing manual chart review and improving care coordination.
The CardioCare platform is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of cardiovascular diseases.
© 2026 egnite, Inc. All Rights Reserved. egnite, egnite Inc., CardioCare, the heart logo, and the spark logo are trademarks of egnite, Inc. All other trademarks are property of their respective owners.
Privacy Policy Intellectual Property Terms of Use Implementation Kit Careers